Table 3.
Symptoms | Overall BII cohort | Explantation cohort |
||
---|---|---|---|---|
Explanters with symptoms | Explanters with symptom improvement | P-value | ||
Fatigue | 155 (92) | 66 (94) | 50 (76) | < 0.001 |
Headache | 103 (61) | 44 (63) | 35 (80) | < 0.001 |
Anxiety | 117 (70) | 51 (73) | 39 (76) | < 0.001 |
Depression | 107 (64) | 48 (69) | 36 (75) | < 0.001 |
Vertigo | 78 (46) | 34 (49) | 28 (82) | < 0.001 |
Brain fog | 159 (95) | 66 (94) | 48 (73) | < 0.001 |
Poor sleep | 114 (68) | 46 (66) | 37 (80) | < 0.001 |
Changes in vision | 115 (68) | 51 (73) | 28 (55) | < 0.001 |
Changes in hearing | 69 (41) | 29 (41) | 14 (48) | < 0.001 |
Joint pain | 135 (80) | 58 (83) | 45 (78) | < 0.001 |
Muscle pain | 111 (66) | 47 (67) | 31 (66) | < 0.001 |
Numbness | 112 (67) | 51 (73) | 38 (75) | < 0.001 |
Cold/tingling limbs | 75 (45) | 37 (53) | 24 (65) | < 0.001 |
Breast discomfort | 113 (67) | 45 (64) | 41 (91) | < 0.001 |
Rashes | 74 (44) | 37 (53) | 26 (70) | < 0.001 |
Hair loss | 124 (74) | 56 (80) | 33 (59) | < 0.001 |
Dry skin | 114 (68) | 52 (74) | 33 (63) | < 0.001 |
Dry eyes | 95 (57) | 41 (59) | 24 (59) | < 0.001 |
Easing bruising | 78 (46) | 28 (40) | 12 (43) | < 0.001 |
Changes in bladder habits | 58 (35) | 25 (36) | 14 (56) | < 0.001 |
Changes in bowel habits | 73 (43) | 25 (36) | 12 (48) | < 0.001 |
Food intolerance | 93 (55) | 38 (54) | 16 (42) | < 0.001 |
Metallic taste | 39 (23) | 15 (21) | 12 (80) | < 0.001 |
Weight problems | 111 (66) | 45 (64) | 19 (42) | < 0.001 |
Thyroid disorder | 68 (40) | 34 (49) | 14 (41) | < 0.001 |
Hormone imbalance | 80 (48) | 37 (53) | 17 (46) | < 0.001 |
Early menopause | 29 (17) | 14 (20) | 5 (36) | 0.063 |
Decreased libido | 116 (69) | 53 (76) | 22 (42) | < 0.001 |
Poor healing | 64 (38) | 32 (46) | 14 (44) | < 0.001 |
Fevers or night sweats | 85 (51) | 37 (53) | 22 (59) | < 0.001 |
Persistent infections | 44 (26) | 23 (33) | 18 (78) | < 0.001 |
Swollen lymph nodes | 84 (50) | 36 (51) | 32 (89) | < 0.001 |
Values are presented as number (%).
BII, breast implant illness.